A novel small molecule glycolysis inhibitor WZ35 exerts anti-cancer effect via metabolic reprogrammi...
A novel small molecule glycolysis inhibitor WZ35 exerts anti-cancer effect via metabolic reprogramming
About this item
Full title
Author / Creator
Wang, Lihua , Zhu, Zheng , Liang, Qi , Tao, Yecheng , Jin, Gaowei , Zhong, Yaoyao , Dai, Jichen , Dai, Ruixia , Wang, Zhixiang , Chen, Junbo , Zhou, Lingjie , Ke, Shouyu , Zheng, Bin , Lan, Linhua , Lin, Xiaokun and Chen, Tongke
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Liver cancer is the fifth leading cause of cancer death worldwide, but early diagnosis and treatment of liver cancer remains a clinical challenge. How to screen and diagnose liver cancer early and prolong the survival rate is still the focus of researchers.
Cell experiments were used to detect the effect of WZ35 on the colony formation ability a...
Alternative Titles
Full title
A novel small molecule glycolysis inhibitor WZ35 exerts anti-cancer effect via metabolic reprogramming
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_3b039187b7394c83a36cf2c133443db8
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3b039187b7394c83a36cf2c133443db8
Other Identifiers
ISSN
1479-5876
E-ISSN
1479-5876
DOI
10.1186/s12967-022-03758-0
